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Polymorphonuclear neutrophils (PMNs) play a critical
role in host defense against bacterial pathogens. PMNs
elaborate a number of proteases that are involved in
host immunity and are capable of bactericidal activity
(1, 2). However, proteolytic enzymes released by PMNs
also degrade extracellular matrix components, leading
to tissue damage and chronic inflammation (3, 4). For
example, PMNs are a prominent feature of joint
inflammation in rheumatoid arthritis, and are thought
to be responsible for the cartilage destruction in this
disease. Therefore, the prevention of PMN migration
and accumulation at inflammatory sites may limit
their host-damaging effector functions.
PMNs express a family of neutral serine proteases in
their azurophil (primary) granules. These PMN-specif-
ic, granule-associated enzymes include cathepsin G
(CG), neutrophil elastase (NE), and proteinase 3 (PR3)
(5). Another structurally related granule-associated
protein is azurocidin, which has no enzymatic activity
(6). While their protective role in host immunity is
acknowledged (7, 8), the role of PMN-derived serine
proteases in neutrophil extravasation at sites of inflam-
mation is still controversial.
Due to their proteolytic properties, it has long been
commonly thought that the main function of these
neutrophil-derived proteases at sites of inflammation
is to degrade various components of the extracellular
matrix. The role of serine proteases in PMN recruit-
ment, however, appears to be more complex than sim-
ple disruption of extracellular matrix. Recent evidence
suggests that extracellularly released serine proteases
remain catalytically active (9), and may modulate neu-
trophil recruitment. Inhibition of PMN-derived serine
proteases has been shown to reduce PMN adhesion to
various extracellular matrix–coated surfaces and
endothelial layers ex vivo (10, 11), and neutrophil infil-
tration into inflamed tissues in vivo (12, 13). However,
studies using naturally occurring protease inhibitors,
as well as low-molecular-weight inhibitors, have shown
that serine proteases are not required for successful
PMN transendothelial migration in vitro (14), nor are
they involved in the disruption of subendothelial base-
ment membrane during PMN diapedesis (15).
Recently, proteolysis has emerged as an important
mechanism of regulating cytokine bioactivity (16). For
example, IL-1β and TNF-α are proteolytically processed
to their active form by IL-1β–converting enzyme (ICE,
or caspase-1) and TNF-α–converting enzyme (TACE),
respectively (17, 18). At sites of inflammation, elevated
levels of extracellularly released, neutrophil-derived ser-
ine proteases temporally coincide with high concentra-
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neutrophil elastase [NE], and proteinase 3 [PR3]) are expressed specifically in mature neutrophils and
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inflammation, we generated a mouse deficient in dipeptidyl peptidase I (DPPI) and established that
DPPI is required for the full activation of CG, NE, and PR3. Although DPPI–/– mice have normal in
vitro neutrophil chemotaxis and in vivo neutrophil accumulation during sterile peritonitis, they are
protected against acute arthritis induced by passive transfer of monoclonal antibodies against type II
collagen. Specifically, there is no accumulation of neutrophils in the joints of DPPI–/– mice. This pro-
tective effect correlates with the inactivation of neutrophil-derived serine proteases, since NE–/– × CG–/–
mice are equally resistant to arthritis induction by anti-collagen antibodies. In addition, protease-defi-
cient mice have decreased response to zymosan- and immune complex–mediated inflammation in the
subcutaneous air pouch. This defect is accompanied by a decrease in local production of TNF-α and
IL-1β. These results implicate DPPI and polymorphonuclear neutrophil–derived serine proteases in
the regulation of cytokine production at sites of inflammation.
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tions of bioactive cytokines. This led to the hypothesis
that PMN-derived serine proteases may control inflam-
matory processes through the proteolytic modification
and release of cytokines. However, the extent of their
regulatory functions in various pathophysiological con-
ditions remains largely uncharacterized.
Serine proteases share a high degree of homology, both
at the cDNA and protein levels. Genetic analysis shows
that all of these serine proteases are synthesized as pre-
proenzymes with a residue leader sequence of 18–26
amino acids that is cleaved, leaving a prodipeptide
between the proenzyme and the mature active enzyme
(19). The activation of these proteases requires the
removal of this prodipeptide (20). We recently generated
a mouse with a null mutation in the lysosomal cysteine
protease dipeptidyl peptidase I (DPPI), and showed that
DPPI is essential for the processing and activation of
many serine proteases, including cytotoxic lymphocyte
granzymes A and B (21) and mast cell chymase (22).
In this study, we established that DPPI is important for
the processing and activation of the PMN-derived serine
proteases NE, CG, and PR3. Although DPPI- and serine
protease–deficient mice have normal in vitro chemotaxis
and in vivo peritonitis in response to thioglycollate, they
are resistant to acute arthritis induction by passive trans-
fer of anti–type II collagen antibodies. Moreover, they
have a defect in neutrophil recruitment in subcutaneous
air pouches in response to zymosan and immune com-
plexes. The decrease in inflammatory cell accumulation
correlates with a decrease in cytokine production. These
studies support the hypothesis that neutrophil-derived
serine proteases are involved in the regulation of
cytokine production at sites of inflammation.
Methods
Animals. DPPI–/–, CG–/–, NE–/–, and NE–/– × CG–/– mice,
all in the 129 genetic background, were produced as
previously described (7, 21, 23). These mice and wild-
type (WT) control mice were kept in pathogen-free con-
ditions at Washington University Specialized Research
Facility. For in vitro analysis, mice 4–8 weeks of age
were used. For in vivo experiments, male mice 6–8
weeks of age were used. 
Western blot analysis. Protein lysates were prepared
from PMNs or bone marrow as previously described
(23). Equivalent amounts of total protein were loaded
onto 10% SDS-PAGE gels, transferred to nitrocellulose,
and blotted with anti-NE and anti-CG antisera as pre-
viously described (7, 23). β-actin served as control for
quantity and quality of protein.
S1 analysis. Total cellular RNA was prepared from
bone marrow cells and analyzed by S1 nuclease protec-
tion assay using CG-specific probe as previously
described (23). Murine β2 microglobulin served as con-
trol for quantity and quality of RNA.
Determination of enzymatic activity. Total bone marrow
cell lysates were prepared as previously described (23)
and normalized for protein content. NE activity was
measured using the peptide substrate N-methoxysuc-
cinyl-Ala-Ala-Pro-Val-pNA (Elastin Products Co.,
Owensville, Missouri, USA); CG activity was measured
using the substrate N-succinyl-Ala-Ala-Pro-Phe-pNA
(Sigma-Aldrich, St. Louis, Missouri, USA); and PR3
activity was measured using the substrate N-t-buty-
loxycarbonyl-Ala-Ala-Nva-thiobenzyl ester (Elastin
Products Co.), as previously described (23).
In vitro chemotaxis. Neutrophils were purified from
bone marrow using a discontinuous Percoll gradient
(Amersham Pharmacia Biotech, Piscataway, New Jersey,
USA). Neutrophil purity was consistently 75–85%, as
assessed by light microscopy of Wright-Giemsa–stained
cytospins. Neutrophils were labeled with calcein AM
(Molecular Probes Inc., Eugene, Oregon, USA), and
placed on top of a 96-well chemotaxis chamber (Neuro
Probe Inc., Gaithersburg, Maryland, USA). The bottom
wells of the microplate were filled with either the
chemotactic agent fMLP (10–4 M), or zymosan-activat-
ed rat serum (2%, as a source of C5a), or recombinant
human IL-8 (rhIL-8) (3 µg/ml; Amersham Pharmacia
Biotech), or buffer. After incubation for 1 hour at 37°C
in an atmosphere of 5% CO2, the nonmigrating cells
from the top of the filter were removed, and the cells
(tested in triplicate per point) that migrated to the bot-
tom chamber were measured using a fluorescent plate
reader (Bio-Tek Instruments Inc., Winooski, Vermont,
USA). The fluorescence for each well was expressed as a
percentage of total PMNs.
Superoxide production. Purified bone marrow–derived
neutrophils were resuspended in HBSS containing
1.3 mM CaCl2 and 0.4 mM MgSO4, and stimulated
with PMA in the presence of 0.2 mM cytochrome c.
The kinetics of superoxide dismutase–inhibitable
reduction of cytochrome c was assessed by measuring
nmol of O2– produced by 106 PMNs over a period of
30 minutes, at OD550.
Thioglycollate-induced peritonitis. Mice were injected
with 1 ml of thioglycollate broth intraperitoneally, and
at the indicated timepoints, peritoneal cells were har-
vested by lavage and quantified.
Arthritis induced by anti–type II collagen antibody. Mice were
injected intravenously with a cocktail of 4 mg of
anti–type II collagen antibodies (Chemicon Internation-
al Inc., Temecula, California, USA) on day 0, followed by
50 µg of intraperitoneal LPS on day 3 as recommended
by the manufacturer. Severity of arthritis in each paw was
scored as follows: 0 = normal; 1 = mild redness and
swelling of digits, ankle, or wrist; 2 = moderate swelling
of ankle or wrist; 3 = severe swelling involving entire paw,
including digits (maximum score of 12 per mouse).
Histological grading of arthritis. At least four mice per
genotype were sacrificed, and all four paws of each
mouse were excised and fixed in 10% buffered formalin.
Fixed tissues were decalcified in 14% EDTA for 2 weeks,
and then dehydrated and embedded in paraffin. Sagittal
sections of talocrural or radiocarpal joints were stained
with either hematoxylin and eosin or toluidine blue
using standard techniques. Cells infiltrating the synovial
and subsynovial space were identified by morphology
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and photographed using the LE-Digital 1-CCD video
camera system (Optronics, Goleta, California, USA). Cell
counts and differentials of four random high-power
fields (HPFs) of each joint section were performed by the
same blinded observer. Joint exudates were scored on a
scale of 0 (normal) to 5 (severe, with presence of inflam-
matory cells fibrin-like material occupying more than
60% of the joint space). Proteoglycan depletion was
scored on toluidine blue–stained sections on a scale of
0–3 (0 = fully stained cartilage, 1 = less than 25%
unstained cartilage, 2 = 25–50% unstained cartilage, and
3 = more than 50% unstained cartilage).
Subcutaneous air pouch. The air pouches were formed
according to the method of Edwards et al. (24). Mice
were anesthetized, and air pouches were created by sub-
cutaneous injection of 5 ml of sterile air into the back.
The pouches were reinflated 3 days later with 3 ml of
sterile air. On day 6, the pouches were instilled with
either 1 µg of rIL-8, 0.3 ml of 1% zymosan, or normal
saline. At the indicated times, the mice were sacrificed,
the pouches were lavaged with 5 ml of PBS, and the
number of PMNs was determined.
Reverse passive Arthus reaction. Mice were injected intra-
venously with 20 mg/kg chicken ovalbumin (OVA), fol-
lowed by instillation of 300 µg heat-inactivated rabbit
anti-OVA antibodies (Sigma-Aldrich) in the air pouch
to induce immune complex formation in situ. Mice
treated with normal saline in the air pouch after intra-
venous injection of OVA served as controls. At indicat-
ed times after challenge, mice were sacrificed, and their
pouches were lavaged as above.
Induction and measurement of cytokines. Mice were
injected intraperitoneally with 50 µg or 100 µg of E. coli
LPS, serotype 0127:B8 (Sigma-Aldrich), in 100 µl of
sterile PBS. Sera were collected before and 90 minutes
after LPS challenge. TNF-α levels were determined
using an ELISA kit (R&D Systems Inc., Minneapolis,
Minnesota, USA) per the manufacturer’s protocol.
TNF-α and IL-1β levels in air pouch supernatants col-
lected at 12 hours after injection were also measured by
ELISA as recommended by the manufacturer.
In vitro neutrophil degranulation. In vitro degranulation
assays were performed as previously described (25).
Bone marrow–derived neutrophils were resuspended in
HBSS at 107/ml, and stimulated with 50 ng/ml PMA
for 15 minutes. The cells were pelleted, and the super-
natant was analyzed by gelatin zymography for matrix
metalloproteinase 9 (MMP-9) activity. Briefly, the
supernatant was subjected to SDS-PAGE on gels con-
taining 1% gelatin under nonreducing conditions.
After electrophoresis, gels were washed twice with 2.5%
Triton X-100 for 30 minutes to remove SDS, and then
incubated overnight at 37°C in reaction buffer con-
taining 50 mM Tris (pH 7.4), 150 mM NaCl, and 5 mM
CaCl2. Gelatinolytic activity appeared as colorless
bands against a blue background when stained with
0.125% Coomassie brilliant blue.
Statistical analysis. Wilcoxon’s two-tailed rank sum
test for unpaired variables was used to compare dif-
ferences between groups. P values of less than 0.05
were considered significant.
Results
DPPI–/– mice have normal granulocyte development. We
analyzed the hematopoietic development of multiple
DPPI–/– mice derived from two different embryonic
stem cell lines. Complete blood counts and differen-
tials showed normal counts of circulating white blood
cells (WBCs) and mature granulocytes (PMNs) in
both WT (9.08 ± 2.7 × 103 WBCs/µl with 24.7% ± 7.7%
PMNs) and DPPI–/–animals (8.79 ± 3.48 × 103
WBCs/µl with 24.4% ± 10.9% PMNs). Cytospins of
bone marrow cells derived from 4- to 8-week-old WT
and DPPI–/– mice revealed normal numbers of myeloid
precursors and mature granulocytes (data not
shown). Transmission electron microscopy of bone
marrow–derived PMNs from DPPI–/– mice showed
normal numbers of electron-dense azurophil granules
and normal neutrophil morphology (data not
shown). In addition, we have previously shown that
PMNs derived from DPPI–/– mice express normal sur-
face levels of Gr-1 and Mac-1 (21).
The Journal of Clinical Investigation | February 2002 | Volume 109 | Number 3 365
Figure 1
Analysis of PMN-derived serine proteases in DPPI–/– mice.
NE (a) and CG (b) protein expression in DPPI–/– bone
marrow lysates. β-actin served as control for protein con-
tent. Note the markedly reduced level of immunoreactive
CG in DPPI–/– bone marrow lysate compared with WT.
(c) S1 nuclease protection assay revealed equivalent lev-
els of CG mRNA in DPPI–/– and WT bone marrow lysate.
β2 microglobulin (β2m) served as control for RNA load-
ing. (d) DPPI–/– bone marrow cells and NE–/– bone mar-
row cells have equivalent residual levels of NE activity. (e)
Both DPPI–/– and CG–/– bone marrow cells have no
detectable hydrolysis of the CG-specific peptide sub-
strate. (f) Conversion of the PR3 substrate by DPPI–/–
bone marrow cell lysate was reduced by 80% compared
with WT. Relative enzyme activity was measured at OD405
per 105 bone marrow cells and values represent mean
activity ± SEM of at least three animals. 
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Serine protease activity is severely reduced in DPPI–/– neu-
trophils. Western blot analysis using NE-specific poly-
clonal rabbit anti-mouse sera confirmed equal
immunoreactive NE bands in WT and DPPI–/– PMN
lysates (Figure 1a). However, the amount of immunore-
active CG was markedly reduced in DPPI–/– lysates (Fig-
ure 1b), despite normal levels of mRNA detected by S1
analysis (Figure 1c). To rule out the possibility that this
decreased level was due to nonspecific proteolytic activ-
ity that occurred after the cells were lysed, we per-
formed immunohistochemistry on cytospin samples of
bone marrow cells using the CG-specific antibody. We
confirmed that immunoreactive levels of CG were
reduced in DPPI–/– PMNs prior to cell lysis (data not
shown). Therefore, DPPI not only activates these pro-
teases but may influence the total levels of these
enzymes in some instances.
Using chromogenic substrates, we measured the spe-
cific activity of each granule-associated serine protease
expressed in the myeloid compartment. NE activity in
DPPI–/– bone marrow lysate, as assessed by measuring
the hydrolysis of N-methoxysuccinyl-Ala-Ala-Pro-Val-
pNA, was equivalent to that seen in the NE–/– bone mar-
row extract (Figure 1d). CG activity, as assayed by the
hydrolysis of N-succinyl-Ala-Ala-Pro-Phe-pNA, was vir-
tually absent in DPPI–/– bone marrow lysate (Figure 1e).
Lastly, PR3 activity, as assayed by the hydrolysis of N-t-
butyloxycarbonyl-Ala-Ala-Nva-thiobenzyl ester, was
reduced by 80% in DPPI–/– lysate (Figure 1f). It is diffi-
cult to assess whether this residual amount of activity is
due to low levels of active PR3 enzyme, since PR3-defi-
cient mice are currently unavailable. Since chromogenic
substrates are not entirely specific for a given enzyme, it
is likely that the apparent detection of residual NE and
PR3 activities in DPPI–/– bone marrow is attributable to
irrelevant proteases. However, we have previously shown
that granzyme C and mast cell tryptase can be processed
to the active form in the absence of DPPI (21, 22). There-
fore, sensitive immunological assays that specifically
detect the mature form of each of the three serine pro-
teases will be necessary to firmly establish that DPPI–/–
neutrophils lack all mature CG, NE, and PR3. Never-
theless, these results confirmed that DPPI plays an
important role in the processing and full activation of
all three PMN-derived serine proteases in vivo.
DPPI–/– mice have normal in vitro neutrophil chemotaxis and
in vivo thioglycollate-induced peritonitis. Neutrophil chemo-
taxis was examined using a modified Boyden chamber.
Calcein AM–labeled PMNs were allowed to migrate in
response to fMLP (10–4 M), zymosan-activated rat serum
(2%), and rhIL-8 (3 µg/ml). There was no significant dif-
ference in the ability of DPPI–/– PMNs to migrate toward
these stimuli compared with that of WT PMNs (Figure
2a). In addition, DPPI–/– PMNs mobilized a normal res-
piratory burst in response to PMA, as determined by the
kinetics of superoxide dismutase–inhibitable reduction
of cytochrome c (Figure 2b).
The response of DPPI–/– mice to thioglycollate-
induced peritonitis was also assessed. Groups of 4–5
mice were injected intraperitoneally with 1 ml of thio-
glycollate, and the peritoneal exudates were collected
after 4 hours, 24 hours, and 120 hours. Thioglycollate
injection into the peritoneum resulted in equivalent
numbers of total leukocytes and PMNs recovered from
WT mice and DPPI–/– mice at 4 hours and 24 hours
(Figure 2, c and d). Peritoneal lavage at 120 hours after
thioglycollate injection revealed no statistically signif-
icant difference between the numbers of WT and
DPPI–/– macrophages (Figure 2e). Thus, although the
absence of DPPI severely reduced the activity of NE,
CG, and PR3 in PMNs, the lack of serine protease activ-
ity did not affect in vitro neutrophil chemotaxis or in
vivo recruitment of leukocytes in response to thiogly-
collate, a nonspecific inflammatory stimulus.
DPPI–/– mice are resistant to induction of arthritis by passive
transfer of anti–type II collagen antibodies. To further
explore the role of DPPI and PMN-associated serine
protease in a more pathophysiological condition, we
challenged the DPPI-deficient mice to a well-estab-
lished model of acute experimental arthritis (26). Four
milligrams of a cocktail of four separate monoclonal
antibodies specific for the main arthrogenic determi-
nants of type II collagen were injected intravenously
into groups of WT and DPPI–/– mice. On day 3, 50 µg
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Figure 2
In vitro PMN function and in vivo response to thioglycollate in the
absence of DPPI. (a) Bone marrow–derived PMNs from WT and
DPPI–/– mice were allowed to migrate across a filter in response to
10–4 M fMLP, 2% zymosan-activated rat serum (ZAS), or 3 µg/ml
rhIL-8. The number of cells that migrated was expressed as a per-
centage of total PMNs. Values represent the mean ± SEM of at least
three animals. (b) Superoxide production by PMNs in response to
PMA, expressed as nmol of O2– generated per 106 PMNs (n > 3 per
genotype). The number of PMNs and macrophages recruited in
response to intraperitoneal injection of thioglycollate is normal in
DPPI–/– mice at 4 hours (c) 24 hours (d) and 120 hours (e).The
slightly lower number of macrophages at 120 hours after thioglycol-
late injection in the DPPI–/– mice did not reach statistical significance
(n = 4–5 mice per genotype). Mph, macrophages.
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of LPS was injected intraperitoneally into each mouse.
LPS, a strong inducer of proinflammatory cytokines,
has been shown to act synergistically in the induction
of arthritis (26). Joint inflammation developed within
24–48 hours after LPS injection, and peaked around
day 6–7. By day 7, 87.5% of WT mice (n = 16) developed
clinically evident arthritis, with a mean arthritis score
of 6.3 ± 3.3 (maximum score, 12 per mouse). Arthritis
is manifested by redness and swelling of the entire paw,
including digits (Figure 3a). In contrast, none of the
DPPI–/– mice (n = 6) displayed any clinical signs of
inflammation in either joints or digits (Figure 3b).
We performed histological analysis to more precisely
determine the nature of the infiltrating cells. The front
and hind paws of WT and DPPI–/– mice were removed
and processed. Hematoxylin and eosin–stained joint
sections from WT mice revealed extensive infiltration
of the subsynovial tissues by inflammatory cells 
(91 ± 17 cells/HPF). PMNs were the predominant
invading cells (78%), with a smaller contribution from
macrophages and lymphocytes (Figure 3, c, e, and g). In
contrast, very few inflammatory cells (9.1 ± 2.2/HPF, 
P < 0.001) infiltrated the subsynovial space of DPPI–/–
joints (Figure 3, d, f, and h), and the majority of these
cells had macrophage-like morphology. Inflammation
was also assessed by the severity of the inflammatory
exudate in the joint space, and by proteoglycan deple-
tion on toluidine blue–stained sections. Abundant
PMNs were also found in the joint space of WT mice,
along with marked fibrin-like deposition (Figure 3, c
and e). The inflammatory exudate adhered to the joint
surface, which led to proteoglycan depletion, as evi-
denced by the loss of toluidine blue staining (Figure 3i).
In contrast, DPPI–/– joint sections showed no or very
scant exudate (Figure 3, d and f), with preservation of
proteoglycan content in cartilage (Figure 3j). These
results suggest that DPPI–/– joints were protected from
PMN infiltration and cartilage destruction.
In this model of acute arthritis, cartilage-bound
anti–type II collagen antibodies activate the classical
pathway of the complement cascade, leading to the
generation of activated complement components
(27). Using immunohistochemistry, we confirmed
that there were equivalent amounts of anti–type II
collagen antibody and C3 deposition (and activation)
on the cartilage surface of WT and DPPI–/– knee
joints after intravenous injection of monoclonal anti-
bodies (data not shown). To further confirm that the
activation of the late complement components
C5–C9 occurred normally in both genotypes, we per-
formed hemolytic assays using sensitized sheep ery-
throcytes, and sera from WT and DPPI–/– mice. We
found that serum from DPPI–/– mice can activate the
complement cascade and induce red blood cell lysis
to the same extent as WT serum (data not shown).
Therefore, the lack of inflammation in the DPPI–/–
mice is not due to a defect in antigen (type II colla-
gen) recognition by the antibody, or a defect in the
activation of the complement cascade.
To rule out the possibility that the absence of DPPI may
adversely affect the release of granule-associated serine
proteases, we performed in vitro degranulation experi-
ments. Upon stimulation with 50 ng/ml of PMA, WT
and DPPI–/– neutrophils released similar levels of 
MMP-9, as determined by gelatin zymography (Figure
4a). MMP-9 is one of the major proteases released by neu-
trophils upon activation, and is unaffected by the DPPI
mutation. These results suggest that DPPI–/– neutrophils
undergo normal degranulation with stimulation.
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Figure 3
Clinical and histological assessment of monoclonal antibody–induced
arthritis. Forepaw of a WT mouse (a) and a DPPI–/– mouse (b) on day
7 after receiving arthrogenic antibodies against type II collagen. Note
the redness and swelling involving the entire paw, including the digits,
of the WT mouse (a). Histological analysis of sections taken from the
radiocarpal joints of immunized animals, stained with hematoxylin and
eosin (c–h), and toluidine blue (i and j) (to detect proteoglycan). WT
mice (c, e, g, and i) have marked leukocyte infiltration (*) in the sub-
synovial tissue and joint space, adherence of inflammatory cells to joint
surfaces, and proteoglycan loss as evidenced by the reduction in
metachromasia at the superficial border of the cartilage matrix (arrow-
heads). The infiltrating cells are predominantly neutrophils (N) (g).
DPPI–/– mice were protected from arthritis, as evidenced by normal joint
histology, lack of inflammatory infiltrates, and preservation of proteo-
glycan content (d, f, h, and j). Magnification: c and d, ×16; e and f, ×40;
g and h, ×400. E, exudate; C, carpal bones; R, radius; JS, joint space.
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In addition, a recent report suggests that mice defi-
cient in both NE and CG are more resistant than WT
mice are to the effects of LPS (8). Since TNF-α has been
identified as the central cytokine released upon LPS
stimulation, and plays a critical role in inflammatory
joint disease (28), the possibility exists that reduced
serum TNF-α levels in DPPI–/– mice upon LPS chal-
lenge is responsible for the resistance to arthritis. How-
ever, we found that 90 minutes after intraperitoneal
injection of 100 µg of LPS, WT and DPPI–/– mice had
released similar levels of TNF-α into the serum (Figure
4b). We also performed the experiment using 50 µg of
LPS, with similar results (data not shown). Thus, the
lack of inflammation in DPPI–/– mice is not due to a
decrease in serum level of TNF-α in response to sys-
temic administration of LPS.
Resistance to acute arthritis in DPPI–/– mice correlates with
the intrinsic defect in PMN-derived serine protease activity.
DPPI–/– mice have defects in many immune effector cell
functions that may contribute to the observed pheno-
type. To further evaluate the mechanisms involved in
the resistance of susceptibility, we tested whether the
absence of NE and/or CG also conferred resistance to
arthritis. Following injection with anti–type II collagen
monoclonal antibodies and LPS, all CG–/– mice devel-
oped clinical arthritis, with a relatively low mean
arthritic score (3.3 ± 1.5, P < 0.1). NE deficiency alone
considerably attenuated the phenotype; only 75% of
NE–/– mice developed clinically evident arthritis, with a
mean score of 1.8 ± 1.7 (P < 0.02). Similar to the DPPI–/–
mice, the NE–/– × CG–/– mice were all clinically resistant
to the induction of arthritis (Figure 5a).
Histological analysis confirmed the scant presence
of inflammatory cells in the subsynovial space of
NE–/– × CG–/– mice (5.8 ± 2.2 cells/HPF, P < 0.001)
compared with WT mice (91 ± 17 cells/HPF), little if
any exudate in the joint space, and no proteoglycan
loss (Figure 5, b–d). In accordance with the clinical
data, NE–/– mice and CG–/– mice both had fewer
inflammatory cells infiltrating the subsynovial tissue
space than did WT mice (NE–/– mice, 19 ± 8.4
cells/HPF, P < 0.001; CG–/– mice, 42 ± 29 cells/HPF, 
P < 0.01). In addition, both NE–/– and CG–/– joints
showed less exudate and fibrin-like deposition in the
joint space, along with some preservation of proteo-
glycan content in cartilage (Figure 5, c and d). The fact
that the single protease–deficient mice showed an
intermediate phenotype indicates that both NE and
CG contribute to the recruitment of inflammatory
cells, and that the effect is additive.
DPPI–/– mice have decreased response to zymosan- and
immune complex–induced inflammation in the subcutaneous
air pouch. To further elucidate the mechanism(s) under-
lying the joint-protecting effect observed in the protease-
deficient mice, we used the air pouch model of inflam-
mation. Air pouches formed by subcutaneous injection
of air into the back of a mouse develop a lining layer
resembling synovial membrane (24). The air pouch
model therefore provides a suitable space to investigate
the inflammatory responses in synovial-like tissues.
Injection of zymosan into air pouches induced a neu-
trophil influx that peaked at 12 hours (29). This
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Figure 4
In vitro neutrophil degranulation and TNF-α production in DPPI–/–
mice. (a) Purified PMNs (107/ml) were incubated with 50 ng/ml PMA
for 15 minutes, and cell-free supernatants were analyzed by gelatin
zymography. Note that DPPI–/– and WT PMNs released equivalent lev-
els of MMP-9. (b) TNF-α production 90 minutes after intraperitoneal
injection of 100 µg LPS. Open circles represent TNF-α levels prior to
LPS injection. Serum TNF-α levels (filled circles) after LPS injection
were equivalent in WT mice and DPPI–/– mice.
Figure 5
Summary of clinical arthritis and histological scores of immunized mice.
(a) Groups of mice with different genotypes were immunized with
arthrogenic antibodies on day 0, followed by LPS on day 3. Each paw
was evaluated and scored on a scale of 0–3, as outlined in Methods.
Results are expressed as the mean arthritis score on day 7 of all four
paws (maximum score of 12 per mouse). Joint sections were evaluated
by a blinded observer for cellular infiltrate (b), severity of joint exudate
(c), and proteoglycan (PG) depletion(d). Degree of proteoglycan deple-
tion was scored on a scale of 0–3 with 3 being most severe. Results are
expressed as mean ± SEM for each of the histological features, quanti-
fied in WT, DPPI–/–, NE–/– × CG–/–, NE–/–, and CG–/– mice (n = at least
four animals and 16 paws per genotype). *P < 0.01, **P < 0.001.
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response was reduced by 70% in the DPPI–/– mice 
[(11.1 ± 5.1) × 106 PMNs/pouch, n = 4, P < 0.01] com-
pared with WT mice [(37.7 ± 10.3) × 106 PMNs/pouch, 
n = 4] (Figure 6a). Neutrophil recruitment was also defec-
tive in the NE–/– × CG–/– mice [(18.0 ± 9.0) × 106 PMNs/
pouch, n = 5, P < 0.02]. A similar defect in neutrophil
recruitment was seen with the reverse passive Arthus
reaction. WT mice treated with both intravenous OVA
and 300 µg of anti-OVA in the air pouch to induce in situ
formation of immune complexes developed a moderate
but significant neutrophil accumulation in the pouches
[(2.0 ± 0.9) × 106 PMNs/pouch, n = 5] measured 12 hours
after injection (Figure 6b). The number of emigrated
PMNs was reduced in DPPI–/– mice [(0.9 ± 0.5) × 106
PMNs/pouch, n = 5, P < 0.1] and NE–/– × CG–/– mice 
[(0.6 ± 0.3) × 106 PMNs/pouch, n = 4, P < 0.05] (Figure
6b). In fact, the response of NE–/– × CG–/– mice to the
treatment was equivalent to their response to injection
of normal saline into air pouches [(0.7 ± 0.1) × 106
PMNs/pouch, n = 4].
To investigate whether local cytokine production is
normal in this model, we measured levels of TNF-α and
IL-1β in the air pouches following zymosan injection.
Although DPPI–/– mice and NE–/– × CG–/– mice chal-
lenged systemically with LPS showed normal levels of
TNF-α production in serum (ref. 8 and Figure 4b), we
found that local production of TNF-α and IL-1β was
decreased in air pouches of both DPPI–/– mice and
NE–/– × CG–/– mice, compared with those of WT mice
(Table 1). Injection of rhIL-8, a chemokine specific for
neutrophils, into air pouches led to comparable levels
of PMNs recruited in WT and DPPI-deficient mice 
(3.0 ± 1.2 × 106 and 3.8 ± 2.7 × 106 PMNs/ pouch,
respectively, n = 5 per genotype) (Figure 6c). Taken
together, these results suggest that defective local pro-
duction of cytokines (and probably chemokines) con-
tributes to impaired neutrophil recruitment at sites of
inflammation in DPPI–/– mice and NE–/– × CG–/– mice.
Discussion
In this report, we establish that DPPI is essential for the
full activation of CG, NE, and PR3 in vivo. Although cas-
cades of proteolytic activation have been proposed and
confirmed for several series of proteases, it is unlikely
that DPPI initiates a sequence of events during which
DPPI activates CG, which in turn activates NE, which
then activates PR3. Using specific serine protease–defi-
cient mice, we have previously shown that CG–/– neu-
trophils have a normal level of NE activity (23); similar-
ly, NE–/– neutrophils have normal CG activity (25). Since
NE, CG, and PR3 activities are all severely reduced in
DPPI–/– neutrophils, previous reports and this study sug-
gest that all three serine proteases are substrates of DPPI.
In addition, the activation of these proteases requires
cleavage after a glutamic acid residue, a specificity that
is different from the known specificity of each of these
three serine proteases (30). We also found that DPPI–/–
PMNs contain significantly lower amounts of
immunoreactive CG than are found in WT PMNs, but
levels of steady-state mRNA that are basically equivalent
to WT levels. This result is consistent with the previous
observation that unprocessed granzyme A is more sus-
ceptible to degradation in the absence of DPPI (21). In
addition, DPPI also influences the total amount of active
tryptase in bone marrow–derived mast cells (22). Previ-
ous studies have shown that processing of neutrophil-
derived serine proteases is either part of the process of,
or the result of, the sorting of these proteases to
azurophil granules, where these enzymes are stored in
their active form (31). However, sorting may also occur
normally in the absence of the prodipeptide (32). There-
fore, it is likely that in the absence of DPPI, these
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Figure 6
Neutrophil recruitment in air pouch model. Neutrophil recruitment
in response to zymosan (ZS) (a), immune complex (IC) formation
(b), and rhIL-8 (c). Mice were sacrificed 12 hours after injection of
ZS and IC formation and 4 hours after rhIL-8. Each point represents
the number of PMNs in an individual pouch. NS, normal saline.
Table 1
Defective cytokine production in DPPI–/– and NE–/– × CG–/– mice
Genotype Treatment TNF-α IL-1β
(pg/ml) (pg/ml)
WT Saline 11 ± 2 9 ± 1
Zymosan 60 ± 9 899 ± 137
DPPI–/– Saline 11 ± 2 33 ± 9
Zymosan 35 ± 7A 538 ± 144B
NE–/– × CG–/– Saline 11 ± 1 12 ± 4
Zymosan 30 ± 1C 542 ± 199B
Groups of 4–5 mice were injected with 0.3 ml of 1% zymosan or normal saline
into air pouches created 6 days before. Animals were sacrificed 12 hours
later, and the lavage fluid was assayed for the specified cytokine. AP < 0.01,
BP < 0.02, CP < 0.001.
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enzymes persist in a proform that can be missorted into
a different granule compartment (32). Neutrophils
express several classes of granules (azurophil, specific,
gelatinase, and secretory), and missorting of azurophil
granule serine proteases potentially targets them for
degradation. The fact that the CG level is reduced while
the NE level is not also suggests that individual granule
proteases may not be sorted in an identical manner.
Although recent reports suggest that membrane-
bound serine proteases play a role in chemotaxis (33, 34),
we found that DPPI–/– PMNs migrate normally in vitro in
response to optimal concentrations of various chemoat-
tractants. In addition, using a model of nonspecific
inflammation induced by intraperitoneal injection of
thioglycollate, we showed that leukocyte recruitment into
the peritoneum is normal in these mutant mice. These
observations are in agreement with recent studies that
report normal neutrophil chemotaxis and neutrophil
accumulation during sterile and infectious peritonitis in
CG–/–, NE–/–, and NE–/– × CG–/– mice (7, 8, 23).
Recent evidence suggests that PMN-derived serine
proteases are also expressed on the neutrophil surface,
and are active and protected from naturally circulating
inhibitors (9). This concentrated expression of serine
proteases on the surface of PMNs could be important
for the processing of cytokines. Several studies suggest
that PMN-derived serine proteases are involved in the
control of cytokine production. PR3 has been shown to
be a potent activator of membrane-bound TNF-α and
pro–IL-1β (35). CG, NE, and PR3 have been reported to
catalyze the release of more active forms of CXC
chemokines, such as IL-8 and epithelial cell–derived
neutrophil activating protein-78 (ENA-78), through
proteolytic processes (36, 37). In addition, PR3 and NE
also enhance the production of IL-8 by endothelial cells
(38, 39). Therefore, it is reasonable to hypothesize that
the interaction between serine proteases and cytokines
amplifies the necessary signals that sustain neutrophil
recruitment at sites of inflammation.
Using a well-defined acute experimental arthritis model
and the subcutaneous air pouch, we showed that the
absence of DPPI and active serine proteases totally abro-
gated antibody-mediated acute arthritis, and significant-
ly attenuated the response to zymosan and immune com-
plex–induced inflammation in the subcutaneous air
pouch. In the arthritis model, immune complex forma-
tion led to the activation of the classical pathway of the
complement cascade and the generation of C5a.
Although the activated complement component C5a is a
potent chemoattractant, it has a short half-life. Other
cytokines and factors may be needed for maximal inflam-
matory cell recruitment. NE has previously been shown
to play a critical role in sustaining recruitment of PMNs
in bullous pemphigoid induced in the mouse, another
model of antibody-mediated inflammation of the skin
(25). In that report, the authors hypothesize that NE-
mediated extracellular matrix degradation products, such
as elastin fragments, are chemotactic for neutrophils.
Our present studies extend the role of PMN-derived ser-
ine proteases to regulatory functions in the cytokine net-
work. Although DPPI–/– mice and NE–/– × CG–/– mice pro-
duced normal serum levels of TNF-α in response to sys-
temically administered LPS (ref. 8 and Figure 4b), the
local cytokine response in the air pouch was reduced by
approximately 50% compared with the response in WT
mice. In addition, injection of IL-8, a chemokine specific
for neutrophils, led to an equivalent number of PMNs
recruited into DPPI-deficient air pouches. Taken togeth-
er, these results support the concept that DPPI- and ser-
ine protease–deficient PMNs do not have an intrinsic
defect in their ability to transmigrate across the endothe-
lial barrier into the air pouch environment in response to
CXC-like chemokines. Instead, the findings are in keep-
ing with the concept that serine proteases modulate the
local release and/or processing of cytokines, and possibly
of chemokines. However, the possibility remains that
DPPI–/– PMNs and NE–/– × CG–/– PMNs respond differ-
entially to other chemoattractants that are generated
locally in the inflamed joint.
Alternatively, PMNs may preferentially use proteases to
infiltrate certain extracellular matrix–rich environments
(such as the joints) during specific inflammatory
responses. In the extravascular space, directional cell
motility depends on both adhesion and subsequent
detachment. The extracellular expression of proteases
could represent a general mechanism used by various cell
types to regulate locomotion. For example, the binding
of urokinase-type plasminogen activator (uPA, a serine
protease) to its receptor is an important system regulat-
ing cell migration and invasiveness in normal and patho-
logical conditions (40). The matrix metalloprotease
MMP-2 colocalizes with the surface integrin αvβ3 on
angiogenic blood vessels, and has been shown to play an
essential role in angiogenesis by promoting cell migration
(41). Recent evidence suggests that PMN-derived serine
proteases expressed on the neutrophil surface may asso-
ciate with CD11b/CD18 (Mac-1), the major integrin on
the PMN surface (42). This concentrated expression of
serine proteases on the surface of cells could be impor-
tant for the detachment and locomotion of PMNs, espe-
cially in an extracellular matrix–rich environment such as
the synovium. It is likely that at specific inflammatory
sites, excessive adhesion may actually interfere with effi-
cient movement of neutrophils. Therefore, surface-
bound serine proteases may promote the release of PMNs
from their integrin-mediated adhesion by cleaving the
tethering association between integrins and their ligands.
In fact, purified human NE has been shown to cleave sur-
face ICAM-1 and recombinant soluble ICAM-1 (43), and
both NE and CG can cleave VCAM-1 (44).
In summary, this study has established that DPPI is
the major enzyme activating neutrophil-derived serine
proteases in vivo. The importance of these proteases in
inflammatory processes was demonstrated by the dra-
matic protection against arthritis development in an in
vivo model of acute inflammatory arthritis. These
observations also extend the role of neutrophil-derived
proteases in inflammation beyond degradation of
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extracellular matrix components, and strongly impli-
cate these proteases in the control of cytokine produc-
tion. This amplification process by PMN-derived serine
proteases on the cytokine network points to new direc-
tions in therapeutic interventions that may potentially
limit the deleterious effects of excessive neutrophil
influx at sites of inflammation. Lastly, it would be of
interest to investigate whether these enzymes also play
a role in other arthritis models, especially those with
more chronic inflammation in which PMNs are not the
predominant cell type, such as arthritis induced by
active immunization with heterologous type II collagen.
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